Cargando…

Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients

BACKGROUND: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia is an emerging infection. Our objective was to determine the molecular features of hVISA strains isolated from bacteremic patients and to compare them to methicillin resistant S. aureus (MRSA) and methicillin...

Descripción completa

Detalles Bibliográficos
Autores principales: Maor, Yasmin, Lago, Levona, Zlotkin, Amir, Nitzan, Yeshayahu, Belausov, Natasha, Ben-David, Debby, Keller, Nathan, Rahav, Galia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749053/
https://www.ncbi.nlm.nih.gov/pubmed/19732456
http://dx.doi.org/10.1186/1471-2180-9-189
_version_ 1782172160972816384
author Maor, Yasmin
Lago, Levona
Zlotkin, Amir
Nitzan, Yeshayahu
Belausov, Natasha
Ben-David, Debby
Keller, Nathan
Rahav, Galia
author_facet Maor, Yasmin
Lago, Levona
Zlotkin, Amir
Nitzan, Yeshayahu
Belausov, Natasha
Ben-David, Debby
Keller, Nathan
Rahav, Galia
author_sort Maor, Yasmin
collection PubMed
description BACKGROUND: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia is an emerging infection. Our objective was to determine the molecular features of hVISA strains isolated from bacteremic patients and to compare them to methicillin resistant S. aureus (MRSA) and methicillin sensitive S. aureus (MSSA) blood isolates. RESULTS: We assessed phenotypic and genomic changes of hVISA (n = 24), MRSA (n = 16) and MSSA (n = 17) isolates by PCR to determine staphylococcal chromosomal cassette (SCCmec) types, Panton-Valentine leukocidin (PVL) and the accessory gene regulator (agr) loci. Biofilm formation was quantified. Genetic relatedness was assessed by PFGE. PFGE analysis of isolates was diverse suggesting multiple sources of infection. 50% of hVISA isolates carried SCCmec type I, 21% type II; 25% type V; in 4% the SCCmec type could not be identified. Among MRSA isolates, 44% were SCCmec type I, 12.5% type II, 25% type V, 12.5% were non-typable, and 6% were SCCmec type IVd. Only one hVISA isolate and two MSSA isolates carried the PVL. Biofilm formation and agr patterns were diverse. CONCLUSION: hVISA isolates were diverse in all parameters tested. A considerable number of hVISA and MRSA strains carried the SCCmec type V cassette, which was not related to community acquisition.
format Text
id pubmed-2749053
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27490532009-09-23 Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients Maor, Yasmin Lago, Levona Zlotkin, Amir Nitzan, Yeshayahu Belausov, Natasha Ben-David, Debby Keller, Nathan Rahav, Galia BMC Microbiol Research article BACKGROUND: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia is an emerging infection. Our objective was to determine the molecular features of hVISA strains isolated from bacteremic patients and to compare them to methicillin resistant S. aureus (MRSA) and methicillin sensitive S. aureus (MSSA) blood isolates. RESULTS: We assessed phenotypic and genomic changes of hVISA (n = 24), MRSA (n = 16) and MSSA (n = 17) isolates by PCR to determine staphylococcal chromosomal cassette (SCCmec) types, Panton-Valentine leukocidin (PVL) and the accessory gene regulator (agr) loci. Biofilm formation was quantified. Genetic relatedness was assessed by PFGE. PFGE analysis of isolates was diverse suggesting multiple sources of infection. 50% of hVISA isolates carried SCCmec type I, 21% type II; 25% type V; in 4% the SCCmec type could not be identified. Among MRSA isolates, 44% were SCCmec type I, 12.5% type II, 25% type V, 12.5% were non-typable, and 6% were SCCmec type IVd. Only one hVISA isolate and two MSSA isolates carried the PVL. Biofilm formation and agr patterns were diverse. CONCLUSION: hVISA isolates were diverse in all parameters tested. A considerable number of hVISA and MRSA strains carried the SCCmec type V cassette, which was not related to community acquisition. BioMed Central 2009-09-04 /pmc/articles/PMC2749053/ /pubmed/19732456 http://dx.doi.org/10.1186/1471-2180-9-189 Text en Copyright ©2009 Maor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Maor, Yasmin
Lago, Levona
Zlotkin, Amir
Nitzan, Yeshayahu
Belausov, Natasha
Ben-David, Debby
Keller, Nathan
Rahav, Galia
Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
title Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
title_full Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
title_fullStr Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
title_full_unstemmed Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
title_short Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
title_sort molecular features of heterogeneous vancomycin-intermediate staphylococcus aureus strains isolated from bacteremic patients
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749053/
https://www.ncbi.nlm.nih.gov/pubmed/19732456
http://dx.doi.org/10.1186/1471-2180-9-189
work_keys_str_mv AT maoryasmin molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT lagolevona molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT zlotkinamir molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT nitzanyeshayahu molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT belausovnatasha molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT bendaviddebby molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT kellernathan molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients
AT rahavgalia molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients